irinotecan has been researched along with Day Blindness in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boige, V; Boilève, A; Ducreux, M; Jozwiak, M; Le Roy, F; Malka, D; Paques, M | 1 |
1 other study(ies) available for irinotecan and Day Blindness
| Article | Year |
|---|---|
Vision loss after chemotherapy: an irinotecan-induced retinopathy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Female; Humans; Irinotecan; Middle Aged; Retinal Diseases; Vision Disorders | 2019 |